Organogenesis Holdings (ORGO) Retained Earnings: 2016-2025
Historic Retained Earnings for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to -$46.8 million.
- Organogenesis Holdings' Retained Earnings rose 2.10% to -$46.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$46.8 million, marking a year-over-year increase of 2.10%. This contributed to the annual value of -$40.1 million for FY2024, which is 2.10% up from last year.
- Latest data reveals that Organogenesis Holdings reported Retained Earnings of -$46.8 million as of Q3 2025, which was up 31.56% from -$68.3 million recorded in Q2 2025.
- Organogenesis Holdings' 5-year Retained Earnings high stood at -$40.1 million for Q4 2024, and its period low was -$140.8 million during Q1 2021.
- Over the past 3 years, Organogenesis Holdings' median Retained Earnings value was -$46.8 million (recorded in 2025), while the average stood at -$49.0 million.
- In the last 5 years, Organogenesis Holdings' Retained Earnings skyrocketed by 60.76% in 2021 and then crashed by 37.97% in 2024.
- Over the past 5 years, Organogenesis Holdings' Retained Earnings (Quarterly) stood at -$60.8 million in 2021, then grew by 25.53% to -$45.3 million in 2022, then grew by 9.56% to -$41.0 million in 2023, then rose by 2.10% to -$40.1 million in 2024, then climbed by 2.10% to -$46.8 million in 2025.
- Its Retained Earnings was -$46.8 million in Q3 2025, compared to -$68.3 million in Q2 2025 and -$59.0 million in Q1 2025.